| Literature DB >> 21635779 |
Geneviève Lebeau1, Luc DesGroseillers, Wayne Sossin, Jean-Claude Lacaille.
Abstract
Staufens (Stau) are RNA-binding proteins involved in mRNA transport, localization, decay and translational control. The Staufen 1 (Stau1) isoform was recently identified as necessary for the protein synthesis-dependent late phase long-term potentiation (late-LTP) and for the maintenance of mature dendritic spines and synaptic activity in hippocampal CA1 pyramidal cells, strongly suggesting a role of mRNA regulation by Stau1 in these processes. However, the causal relationship between these impairments in synaptic function (spine shape and basal synaptic activity) and plasticity (late-LTP) remains unclear. Here, we determine that the effects of Stau1 knockdown on spine shape and size are mimicked by blocking NMDA receptors (or elevating extracellular Mg2+) and that Stau1 knockdown in the presence of NMDA receptor blockade (or high Mg2+) has no further effect on spine shape and size. Moreover, the effect of Stau1 knockdown on late-LTP cannot be explained by these effects, since when tested in normal medium, slice cultures that had been treated with high Mg2+ (to impair NMDA receptor function) in combination with a control siRNA still exhibited late-LTP, while siRNA to Stau1 was still effective in blocking late-LTP. Our results indicate that Stau1 involvement in spine morphogenesis is dependent on ongoing NMDA receptor-mediated plasticity, but its effects on late-LTP are independent of these changes. These findings clarify the role of Stau1-dependent mRNA regulation in physiological and morphological changes underlying long-term synaptic plasticity in pyramidal cells.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21635779 PMCID: PMC3118231 DOI: 10.1186/1756-6606-4-22
Source DB: PubMed Journal: Mol Brain ISSN: 1756-6606 Impact factor: 4.041
Figure 1Spine changes induced by Stau1 siRNA are prevented by NMDA receptor blockade and high Mg. (A) Confocal images of representative YFP-expressing CA1 pyramidal cells (left) and apical dendrites (right) after co-transfection with siRNA-CTL or siRNA-STAU1 and maintained in normal or elevated Mg2+ (12 mM) to impair NMDAR function. (B) Spine density was reduced by high Mg2+ treatment but not with the NMDA receptor antagonist AP5 (100 μM), and was unchanged by Stau1 siRNA transfection. (C) Cumulative plots of the distribution of spine length for each condition, with summary bar graph of spine length in the inset, showing increased spine length in medium containing high Mg2+ or AP5. Spine length was increased after Stau1 siRNA transfection in normal medium but not in Mg2+ and AP5 treated slices. (D) Summary bar graph of number of regular, elongated and filopodia types of spines in each condition, showing decrease in regular and increase in elongated spines in high Mg2+ or AP5. Stau1 siRNA transfection decreased regular and increased elongated spines in normal medium but not in high Mg2+ or AP5, suggesting that Stau1 effects on spine shape are due to actions on endogenous NMDA receptor-mediated plasticity. Scale bars 25 μm, 5 μm. *, P < 0.05, t-test. Error bars represent s.e.m.
Spine changes induced by NMDA receptor blockade, high Mg2+ and Stau1 siRNA treatment.
| siRNA-CTL | siRNA-STAU1 | |||||
|---|---|---|---|---|---|---|
| Normal medium | High Mg2+ (12 mM) | AP5 | Normal medium | High Mg2+ (12 mM) | AP5 | |
| Spine density (spine/μm) | 0.29 ± 0.02 | 0.21 ± 0.02* | 0.34 ± 0.03 | 0.28 ± 0.02 | 0.19 ± 0.02 | 0.34 ± 0.03 |
| Spine length (μm) | 1.15 ± 0.02 | 1.3 ± 0.02* | 1.3 ± 0.02* | 1.29 ± 0.02§ | 1.35 ± 0.03 | 1.32 ± 0.03 |
| Spine shape | ||||||
| Regular | 49.75 ± 3.1 | 32.3 ± 2.7* | 37.9 ± 2.2* | 31.77 ± 2.2§ | 30.19 ± 3 | 36.8 ± 2.6 |
| Elongated | 40.92 ± 2.3 | 54.68 ± 2.3* | 50.3 ± 2.3* | 51.49 ± 2§ | 51.35 ± 2.7 | 53.1 ± 2.7 |
| Filopodia | 9.33 ± 1.5 | 13.02 ± 1.9 | 11.8 ± 1.6 | 16.74 ± 1.4 | 15.57 ± 3 | 10.2 ± 1.5 |
- Data expressed as mean ± s.e.m from 16-27 neurons per group, 4-8 independent experiments per group; in total 3129 protrusions were analyzed from 101 neurons.
- * indicates significant difference in siRNA-CTL relative to normal medium; P < 0.05, ANOVA.
- § indicates significant difference in siRNA-STAU1 relative to siRNA-CTL in individual condition; P < 0.05, ANOVA.
Figure 2Impairment of FSK-induced L-LTP after Stau1 knockdown during high Mg. (A) Potentiation of fEPSP slope induced by FSK application (50 μM, 15 min) in cultured slices maintained in medium containing high Mg2+ for 48 hours after siRNA-CTL or siRNA-STAU1 transfection. For electrophysiological experiments, slices were tested in conditions with normal NMDA receptor function. Corresponding field potentials before (black line) and after (gray line) FSK application are shown at right. (B) Summary bar graph showing changes in fEPSPs slope 200 min post-FSK application. Significant L-LTP was present in slices transfected with siRNA-CTL but absent in slices transfected with siRNA-STAU1, indicating that Stau1 knockdown still prevents L-LTP after siRNA-STAU1 transfection in high Mg2+. *, P < 0.05, t-test. Error bars represent s.e.m. (C-D) Stau1 siRNA transfection did not affect basal synaptic transmission (C, input-output function; D, paired-pulse facilitation ratio).